ClinConnect ClinConnect Logo
Search / Trial NCT06262360

Changes in Pulmonary Ventilation Distribution Assessed by Electrical Impedance Tomography in Healthy Children Under General Anesthesia

Launched by QUEEN FABIOLA CHILDREN'S UNIVERSITY HOSPITAL · Feb 14, 2024

Trial Information

Current as of June 28, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how different methods of breathing support during anesthesia can affect the lungs of healthy children aged 1 to 6 who are having elective circumcisions. The researchers want to see if using a face mask, a laryngeal mask, or a special kind of laryngeal mask with pressure support makes a difference in how well air spreads throughout the lungs during surgery. They will use a special device called electrical impedance tomography to measure how well the lungs are ventilated, which can help reduce the risk of breathing problems after surgery.

To participate in this study, children must be between 1 and 6 years old and be scheduled for an elective circumcision, with no history of lung or heart conditions. Throughout the process, parents can expect standard monitoring of their child's vital signs and a series of lung measurements taken at different times: before anesthesia, right after it's given, after surgery, and before discharge. It's also important to note that some children might not be eligible to participate for various medical reasons.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Children undergoing elective circumcision
  • Age 1 to 6 years
  • ASA class I or II
  • Exclusion Criteria:
  • Any history of lung diseases, congenital heart diseases or abdominal diseases that could interfere with lungs dynamic.
  • ASA physical status11 \> II.
  • Patients whose weight is less than 10 kg.
  • The use of Jackson-Rees device12.
  • Contraindication for premedication.
  • Contraindication for mask ventilation or laryngeal mask ventilation13.
  • Contraindication for regional anesthesia.
  • Need for opioids administration during surgery.
  • Patients with uncontrollable movements of the body.
  • Inability of parents/tutors to understand French or Dutch.
  • Patients whose parents do not agree with their participation in the study
  • Patients with thoracic perimeters (between 4th and 6th ribs) less than 37.5 cm (minimal size for the pediatric EIT belt) or more than 72 cm (maximal size for the pediatric EIT belt)
  • Patients with damaged skin or impaired skin contact of the electrodes due to wound dressings.
  • Patients with spinal lesions or fractures (acute or recent)
  • Patients with pacemaker, defibrillators, or other electrically active implants

About Queen Fabiola Children's University Hospital

Queen Fabiola Children's University Hospital is a premier pediatric institution dedicated to advancing child health through innovative clinical research and compassionate care. As a leading sponsor of clinical trials, the hospital focuses on developing and evaluating new treatments and therapies for various pediatric conditions. With a multidisciplinary team of experienced clinicians and researchers, the institution fosters a collaborative environment that emphasizes patient safety, ethical standards, and the integration of cutting-edge scientific advancements. Through its commitment to enhancing pediatric healthcare, Queen Fabiola Children's University Hospital aims to improve outcomes for children and adolescents on a global scale.

Locations

Brussels, , Belgium

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported